Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported a net loss attributable to common stockholders of $20.3 million, or $0.15 per basic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE